Health economics in the field of osteoarthritis

Funding Information: M.H. (Mickael Hiligsmann) has received research grant, lecture fees, and/or consulting fees from Amgen, Pfizer, Novartis, Servier, and SMB. C.C. has received honoraria and consulting fees from AMGEN, GSK, Alliance for Better Bone Health, MSD, Eli Lilly, Pfizer, Novartis, Servier...

Full description

Bibliographic Details
Main Author: Hiligsmann, Mickaël (author)
Other Authors: Cooper, Cyrus (author), Arden, Nigel (author), Boers, Maarten (author), Branco, Jaime C. (author), Luisa Brandi, Maria (author), Bruyère, Olivier (author), Guillemin, Francis (author), Hochberg, Marc C. (author), Hunter, David J. (author), Kanis, John A. (author), Kvien, Tore K. (author), Laslop, Andrea (author), Pelletier, Jean Pierre (author), Pinto, Daniel (author), Reiter-Niesert, Susanne (author), Rizzoli, René (author), Rovati, Lucio C. (author), Severens, Johan L.Hans (author), Silverman, Stuart (author), Tsouderos, Yannis (author), Tugwell, Peter (author), Reginster, Jean Yves (author)
Format: article
Language:eng
Published: 2022
Subjects:
Arthroplasty
Cost-effectiveness
Cost-utility
Economics
Methods
Osteoarthritis
Review
Rheumatology
Anesthesiology and Pain Medicine
Online Access:http://hdl.handle.net/10362/145602
Country:Portugal
Oai:oai:run.unl.pt:10362/145602

Internet

http://hdl.handle.net/10362/145602

Similar Items